Publikationer

John-Erik Stig Hansens publikationer
Januar 2001

Videnskabelige publikationer

Virologi
Genterapi
Stamceller
Glykoprotein kemi
Klinisk medicin

Bøger

Avisartikler

Virology

Husemoen LLN, Gram GJ, Hansen J-ES. Application of the polymerase chain reaction in determination of recombinant retrovirus titers as fifty percent endpoints. APMIS 2000, 108:38-44.

Schønning K, Lund O, Lund OS, Hansen J-ES. Stoichiometry of monoclonal antibody neutralization of T-cell line-adapted human immunodeficiency virus type 1. J Virol 1999, 73:8364-8370.

Machuca R, Schønning K, Hansen J-ES, Fomsgaard A, Nielsen C. Transmission of a minor variant of transcriptionally active HIV-1. Scand J Infect Dis 1999, 31:243-249.

Losman B, Biller M, Olofsson S, Schønning K, Lund OS, Svennerholm B, Hansen J-ES, Bolmstedt A. The N-linked glycan of the V3 region of HIV-1 gp120 and CXCR4-dependent multiplication of a human immunodeficiency virus type 1 lymphocyte-tropic variant. FEBS Lett 1999, 454:47-52.

Lund OS, Losman B, Schønning K, Bolmstedt A, Olofsson S, Hansen J-ES. Inhibition of HIV-1 infectivity by co-expression of a wild-type and a defective gp120. AIDS Res Hum Retroviruses 1998, 14:1445-1450.

Olofsson S, Hansen J-ES. Host cell glycosylation of viral glycoproteins: a battlefield for host defence and viral resistance. Scand J Infect Dis 1998, 30:435-440.

Schønning K, Bolmstedt A, Novotny J, Losman B, Lund OS, Nielsen JO, Olofsson S, Hansen J-ES. Induction of antibodies against epitopes inaccessible on the HIV-1 envelope oligomer by immunization with recombinant monomeric gp120. AIDS Res Hum Retroviruses 1998, 14:1451-1456.

Schønning K, Joost M, Gram GJ, Machuca R, Nielsen C, Nielsen JO, Hansen J-ES. Chemokine receptor polymorphism and autologous neutralizing antibody response in long-term HIV-1 infection. J Acquir Immune Defic Syndr Hum Retrovirol 1998, 18:195-202.

Hansen J-ES. Endogene retrovirus i det humane genom. Ugeskr Læger 1998, 160:3695-3698.

Nielsen SD, Sørensen AMM, Schønning K, Lund O, Nielsen JO, Hansen J-ES. Complement-mediated enhancement of HIV-1 infection in peripheral blood mononuclear cells. Scand J Infect Dis 1997, 29:447-452.

Bolmstedt A, Biller M, Hansen J-ES, Moore JP, Olofsson S. Demonstration of peripheral fucose units in N-linked glycans of human immunodeficiency virus type 1 gp120: Effects on glycoprotein conformation. Arch Virol 1997, 142:2465-2481.

Hansen J-ES, Nielsen C, Pedersen IR. Virologi i Danmark - en statusrapport. Ugeskr Læger 1996, 158:1548-1551.

Hemming A, Gram GJ, Bolmstedt A, Losman B, Hansen J-ES, Ricksten A, Olofsson S. Conserved N-linked oligosaccharides of the C-terminal portion of human immunodeficiency virus type 1 gp120 and viral susceptibility to neutralizing antibodies. Arch Virol 1996, 141:2139-2151.

Schønning K, Hansen J-ES. En vaccine mod HIV - status efter ti års forskning. Ugeskr Læger 1996, 158: 7047-7050.

Schønning K, Jansson B, Olofsson S, Nielsen JO, Hansen J-ES. Resistance to V3-directed neutralization caused by an N-linked oligosaccharide depends on the quaternary structure of the HIV-1 envelope oligomer. Virology 1996, 218:134-140.

Hansen J-ES, Jansson B, Gram GJ, Clausen H, Nielsen JO, Olofsson S. Sensitivity of HIV-1 to neutralization by antibodies against O-linked carbohydrate epitopes despite deletion of O-glycosylation signals in the V3 loop. Arch Virol 1996, 141:291-300.

Sjölander S, Hansen J-ES, Lövgren-Bengtsson K, Åkerblom L, Morein B. Induction of homologous neutralizing antibodies in guinea-pigs immunized with two human immunodeficiency virus type 1 glycoprotein gp120-iscom preparations. A comparison with other adjuvant systems. Vaccine 1996, 14:344-352.

Schønning K, Jansson B, Olofsson S, Hansen J-ES. Rapid selection for an N-linked oligosaccharide by monoclonal antibodies directed against the V3-loop of human immunodeficiency virus type 1. J Gen Virol 1996, 77:753-758.

Bolmstedt A, Sjölander S, Hansen J-ES, Åkerblom L, Hemming A, Hu S-L, Morein B, Olofsson S. Influence of N-linked glycans in the V4-V5 region of human immunodeficiency virus type 1 glycoprotein gp160 on induction of a virus-neutralizing humoral response. J Acquir Immune Defic Syndr Hum Retrovirol 1996, 12:213-220.

Lund O, Hansen J, Sørensen AM, Mosekilde E, Nielsen JO, Hansen J-ES. Increased adhesion as a mechanism of antibody-dependent and antibody-independent complement-mediated enhancement of human immunodeficiency virus infection. J Virol 1995, 69:2393-2400.

Arendrup M, Åkerblom L, Heegaard PMH, Nielsen JO, Hansen J-ES. The HIV-1 V3 domain on field isolates: participation in generation of escape virus in vivo and accessibility to neutralizing antibodies. Arch Virol 1995, 140:655-670.

Schønning K, Nielsen C, Iversen J, Nielsen JO, Hansen J-ES. Neutralizing antibodies in slowly progressing HIV-1 infection. J Acquir Immune Defic Syndr Hum Retrovirol 1995, 10:400-407.

Hemming A, Bolmstedt A, Jansson B, Hansen J-ES, Travis B, Hu S-L, Olofsson S. Identification of three N-linked glycans in the V4-V5 region of HIV-1 gp120, dispensable for CD4-binding and fusion activity of gp120. Arch Virol 1994, 134: 335-344.

Gram G, Hemming A, Bolmstedt A, Jansson B, Olofsson S, Åkerblom L, Nielsen JO, Hansen J-ES. Identification of an N-linked glycan in the V1-loop of HIV-1 gp120 influencing neutralization by anti-V3 antibodies and soluble CD4. Arch Virol 1994, 139:253-261.

Olofsson S, Jeansson S, Hansen J-ES. Use of lectins in general and diagnostic virology. In: Doyle RJ, Slifkin M (eds), Lectin-microorganism interactions, Marcel Dekker, New York 1994, pp. 67-109.

Arendrup M, Nielsen JO, Olofsson S, Hansen J-ES. HIV-1 infection of in vitro cultures human monocytes: early events and influence of anti HIV-1 antibodies. Arch Virol 1994, 136:35-52.

Hansen J-ES, Sørensen AM, Olofsson S, Osinaga E, Roseto A. Combination effect on HIV infection in vitro of soluble CD4 and HIV-neutralizing antibodies. Arch Virol 1994, 134:179-184.

Olofsson S, Hansen J-ES. Carbohydrate-specific antibodies: novel candidates for antiviral immunotherapy. Antiviral News 1994, 2:66-67.

Hansen J-ES, Hofmann B, Pallesen T, Clausen H. Rôle of carbohydrate on HIV and possibilities for anti-viral intervention. In: Bock K, Clausen H (eds): Complex carbohydrates in drug research, Alfred Benzon Symposium 36, Munksgaard 1994, pp. 414-427.

Steinaa L, Sørensen AM, Nielsen JO, Hansen J-ES. Antibody to HIV-1 Tat protein inhibits the replication of virus in culture. Arch Virol 1994, 139:263-271.

Sørensen AMM, Nielsen C, Arendrup M, Clausen H, Nielsen JO, Osinaga E, Roseto A, Hansen J-ES. Neutralization epitopes on HIV pseudotyped with HTLV-1: conservation of carbohydrate epitopes. J Acquir Immune Defic Syndr Hum Retrovirol 1994, 7:116-123.

Hansen J-ES, Sørensen AM, Arendrup M, Olofsson S, Nielsen JO, Janzek E, Nielsen C, Loibner H. Enhancement of retroviral infection in vitro by anti-LeY IgG: reversal by humanization of monoclonal mouse antibody. APMIS 1993, 101:711-718.

Gilbert M, Brigido L, Müller WEG, Hansen J-E, Ezekowitz RA, Mills J. Screening for inhibitors of HIV gp120-CD4 binding using an enzyme linked immunosorbent assay. J Virol Meth 1993, 42:1-12.

Lund O, Hansen J, Mosekilde E, Nielsen JO, Hansen J-ES. A model of enhancement and inhibition of HIV infection of monocytes by antibodies against HIV. J Biol Physics 1993, 19:133-145.

Arendrup M, Sönnerborg A, Svennerholm B, Åkerblom L, Nielsen C, Clausen H, Olofsson S, Nielsen JO, Hansen J-ES. Neutralizing antibody response during human immunodeficiency virus type 1 infection: type and group specificity and viral escape. J Gen Virol 1993, 74:855-863.

Sørensen AM, Nielsen C, Mathiesen LR, Nielsen JO, Hansen J-ES. Evaluation of the combination effect of different antiviral compounds against HIV in vitro. Scand J Infect Dis 1993, 25:365-371.

Bolmstedt A, Olofsson S, Sjögren-Jansson E, Jeansson S, Sjöblom I, Åkerblom L, Hansen J-ES, Hu S-L. Carbohydrate determinant NeuAc-Galb (1-4) of N-linked glycans modulates the antigenic activity of human immunodeficiency virus type 1 glycoprotein gp120. J Gen Virol 1992, 73:3099-3105

Hansen J-ES, Nielsen C, Svenningsen A, Witzke N, Mathiesen LR. Synergistic antiviral effect in vitro of azidothymidine and amphotericin B methyl ester in combination on HIV infection. Scand J Infect Dis 1992, 24:35-39.

Arendrup M, Nielsen C, Hansen J-ES, Mathiesen L, Nielsen JO. Autologous HIV-1 neutralizing antibodies: emergence of neutralization resistant escape virus and subsequent development of escape virus neutralizing antibodies. J Acquir Immune Defic Syndr Hum Retrovirol 1992, 5:303-307.

Arendrup M, Nielsen CM, Hansen J-ES, Mathiesen L, Lindhardt BØ, Scheibel E, Nielsen JO. Neutralizing antibodies against two HIV-1 strains in consecutively collected serum samples: cross neutralization and association to HIV-1 related disease. Scand J Infect Dis 1992, 24:21-28.

Hansen J-ES. Initial events of human immunodeficiency virus infection: role of carbohydrate and possibilities for intervention. Doktordisputats, Københavns Universitet, eget forlag 1992.

Hansen J-ES. Carbohydrates of human immunodeficiency virus. APMIS 1992, suppl. 27, vol 100, pp. 96-108.

Hansen J-ES, Clausen H, Hu S-L, Nielsen JO, Olofsson S. An O-linked carbohydrate neutralization epitope of HIV-1 gp120 is expressed by HIV-1 env gene recombinant vaccinia virus. Arch Virol 1992, 126:11-20.

Teglbjærg LLS, Nielsen C, Hansen J-ES. Sensitive non-radioactive detection of HIV-1: use of nested primers for the amplification of HIV DNA. Molec Cell Probes 1992, 6:175-180.

Arendrup M, Hansen J-ES, Nielsen C, Mathiesen LR, Nielsen JO. Antibody to histoblood-group A antigen neutralizes HIV produced by lymphocytes from blood group A donors not from blood group 0 or B donors. AIDS 1991, 5:441-444.

Hansen J-ES, Nielsen C, Vestergaard BF. Inhibition of human immunodeficiency virus 1 (HIV-1) and herpes simplex virus 1 (HSV-1) infectivity with a broad range of lectins. Scand J Infect Dis 1991, 23:425-430.

Hansen J-ES, Nielsen C, Clausen H, Mathiesen L, Nielsen JO. Effect of anti-carbohydrate antibodies on HIV infection in a monocytic cell line (U937). Antivir Res 1991, 16:233-242.

Hansen J-ES, Nielsen C, Mathiesen LR, Nielsen JO. Involvement of lymphocyte function-associated antigen-1 (LFA-1) in HIV infection: inhibition by monoclonal antibody. Scand J Infect Dis 1991, 23:31-36.

Teglbjærg LLS, Hansen J-ES, Dalbøge H, Nielsen CM, Mathiesen L, Nielsen JO. Detection of human immunodeficiency virus DNA in cultured human glial cells by means of the polymerase chain reaction. Acta Neurol Scand 1991, 83:179-182.

Hansen J-ES, Nielsen JO. Hvor er AIDS vaccinen? (Leder). Ugeskr Læger 1991, 153:2935.

Hansen J-ES, Nielsen C, Arendrup M, Olofsson S, Mathiesen LR, Nielsen JO, Clausen H. Broadly neutralizing antibodies targeted to mucin-type carbohydrate epitopes of human immunodeficiency virus. J Virol 1991, 65:6461-6467.

Hansen J-ES, Nielsen JO. Human patogene retrovirus (Leder). Ugeskr Læger 1990, 52:1211.

Hansen J-ES, Mathiesen L, Pedersen C. No effect of isoprinosine on HIV infection in vitro. AIDS 1990, 4:1036-1037.

Hansen J-ES, Witzke NM, Nielsen C, Mathiesen LR, Teglbjærg LS, Nielsen CM, Nielsen JO. Derivatives of amphotericin inhibit infection with human immunodeficiency virus in vitro by different modes of action. Antivir Res 1990, 14:149-160.

Hansen J-ES, Clausen H, Nielsen C, Teglbjærg LS, Hansen LL, Dabelsteen E, Nielsen CM, Mathiesen L, Hakomori S, Nielsen JO. Inhibition of human immunodeficiency virus (HIV) infection in vitro by anticarbohydrate monoclonal antibodies: peripheral glycosylation of HIV envelope glycoprotein gp120 may be a target for virus neutralization. J Virol 1990, 64:2833-2840.

Hansen J-ES, Nielsen CM, Nielsen C, Heegaard P, Mathiesen LR, Nielsen JO. Correlation between the carbohydrate structures on the envelope glycoprotein gp120 from HIV-1 and HIV-2 and syncytium inhibition with lectins. AIDS 1989, 3:635-641.

Gene therapy

Sørensen TU, Gram GJ, Nielsen SD, Hansen J-ES. Safe sorting of GFP-transduced live cells for subsequent culture using a modified FACS Vantage. Cytometry 1999, 37:284-290.

Theilade MD, Gram GJ, Jensen PB, Cianfriglia M, Rørth M, Hansen J-ES. Multidrug resistance and retroviral transduction potential in human small cell lung cancer cell lines. APMIS 1999, 107:851-858.

Lund OS, Hansen J-ES. Inhibition of HIV-1 replication by chimeric phosporothioate oligodeoxynucleotides applied in free solution. Intervirology 1998, 41:63-68.

Nielsen SD, Afzelius P, Ersbøll AK, Nielsen JO, Hansen J-ES. Expression of the activation antigen CD69 predicts functionality of in vitro expanded perpheral blood mononuclear cells (PBMC) from healthy donors and HIV-infected patients. Clin Exp Immunol 1998, 114:66-72.

Gram GJ, Nielsen SD, Hansen J-ES. Spontaneous silencing of humanized Green Fluorescent Protein (hGFP) gene expression from a retroviral vector by DNA methylation. J Hematother 1998, 7:333-341.

Nielsen SD, Afzelius P, Dam-Larsen S, Nielsen C, Nielsen JO, Mathiesen L, Hansen J-ES. Effect of granulocyte colony-stimulating factor (G-CSF) in human immunodeficiency virus-infected patients: increase in numbers of naive CD4 cells and CD34 cells makes G-CSF a candidate for use in gene therapy or to support antiretroviral therapy. J Infect Dis 1998, 177:1733-1736.

Lund O, Lund OS, Gram G, Nielsen SD, Schønning K, Nielsen JO, Hansen J-ES, Mosekilde E. Gene therapy of T helper cells in HIV infection: mathematical model of the criteria for clinical effect. Bull Math Biol 1997, 4:725-745.

Nielsen SD, Nielsen JO, Hansen J-ES. In vitro separation and expansion of CD4 lymphocytes from HIV-infected individuals without activation of HIV infection. J Immunol Meth 1997, 200:107-112.

Hansen J-ES, Gram G, Nielsen SD, Sørensen A, Jensen PB, Sehested M, Nielsen JO, Rørth M. Transduction potential of human retroviruses in highly proliferating small-cell lung cancer cells as well as non-proliferating hematopoietic stem cells. APMIS 1997, 105:723-729.

Hansen J-ES. Genterapi - tekniske muligheder, etiske perspektiver. I: Genterapi. Hvad kan man? Hvad vil vi? Teknologirådet, København 1995, pp. 55-59.

Lund OS, Nielsen JO, Hansen J-ES. Inhibition of HIV-1 in vitro by C-5 propyne phosphorothioate antisense to rev. Antiviral Res 1995, 28:81-91.

Lund OS, Nielsen JO, Hansen J-ES. Retroviral molekylærbiologi: genterapeutiske behandlingsmuligheder? Ugeskr Læger 1995, 157:1332-1334.

Stem cells

Nielsen SD, Sørensen TU, Ersbøll AK, Ngo N, Mathiesen L, Nielsen JO, Hansen J-ES. Decrease in immune activation in HIV-infected patients treated with HAART correlates with the function of hematopoietic progenitor cells and the numbers of naive CD4+ cells. Scand J Infect Dis, in press.

Nielsen SD, Husemoen LLN, Sørensen TU, Gram GJ, Hansen J-ES. FLT3 ligand preserves the uncommitted CD34+CD38- progenitor cells during cytokine prestimulation for retroviral transduction. J Hematother Stem Cell Res 2000, 9:695-701.

Nielsen SD, Clark DR, Hutchings M, Dam-Larsen S, Repping S, Nielsen JO, Mathiesen L, Miedema F, Hansen J-ES. Treatment with granulocyte colony-stimulating factor decreases the capacity of hematopoietic progenitor cells for generation of lymphocytes in human immunodeficiency virus-infected persons. J Infect Dis 1999, 180:1819-1826.

Nielsen SD, Mathiesen L, Nielsen JO, Hansen J-ES. Highly active antiretroviral therapy normalizes the function of progenitor cells in human immunodeficiency virus infected patients. J Infect Dis 1998, 178:1299-1305.

Nielsen SD, Dam-Larsen S, Nielsen C, Wantzin P, Mathiesen L, Hansen J-ES. Recombinant human granulocyte colony-stimulating factor increases circulating CD34 positive cells in patients with AIDS. Ann Hematol 1997, 74:215-220.

Glycoprotein chemistry

Reis CA, Sørensen T, Mandel U, David L, Mirgorodskaya K, Roepstorff P, Kihlberg J, Hansen J-ES, Clausen H. Development and characterization of an antibody directed to an a -N-acetyl-D-galactosamine glycosylated MUC2 peptide. Glycoconjugate J 1998, 15:51-62.

Gram GJ, Hansen J-ES. Characterization of HIV-1 gp120 envelope glycoprotein by lectin analysis. In: Rhodes JM, Milton JD (eds). Methods in molecular medicine: lectin methods and protocols. Humana Press Inc. Totowa, NJ. 1997, 167-174.

Hansen JE, Lund O, Nielsen JO, Hansen J-ES, Brunak S. O-GLYCBASE: A Revised database of O-glycosylated proteins. Nucl Acids Res, 1996, 24:248-252.

Hansen JE, Lund O, Nielsen JO, Brunak S, Hansen J-ES. Prediction of the secondary structure of HIV-1 gp120. Proteins 1996, 25:1-11.

Hansen JE, Lund O, Engelbrecht J, Rapacki K, Bohr H, Mosekilde E, Nielsen JO, Hansen J-ES, Brunak S. Prediction of O-glycosylation of mammalian proteins: specificity patterns of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase. Biochem J 1995, 308:801-813.

Clausen H, Pallesen T, Wandall H, Dabelsteen E, Hansen J-ES. Simple mucin type O-glycans of HIV: enzymatic prediction of glycosylation sites for vaccine construction. In: Bock K, Clausen H (eds): Complex carbohydrates in drug research, Alfred Benzon Symposium 36, Munksgaard 1994, pp. 297-315.

Hansen JE, Lund O, Rapacki C, Clausen H, Mosekilde E, Nielsen JO, Hansen J-ES. Glycosylation and protein conformation. In: Bohr H, Brunak S (eds), Protein structure by distance analysis. IOS Press, Amsterdam 1994, pp. 247-254.

Lundgren B, Koch C, Mathiesen L, Nielsen JO, Hansen J-ES. Glycosylation of the major human Pneumocystis carinii surface antigen. APMIS 1993, 101:194-200.

Hansen J-ES, Pedersen B, Neland K, Bøg-Hansen TC. Affinity electrophoresis with con A: Value of orosomucoid microheterogeneity as a marker in cancer, in: Lectins, Biology, Biochemistry, Clinical Biochemistry, vol. 8, E. van Driessche, H.Franz, S.Beeckmans, U.Pfüller, A.Kallikorm, T.C.Bøg-Hansen, (eds.) Textop, Hellerup, Denmark, pp. 374-378, 1993.

Jarløv JO, Hansen J-ES, Rosdahl VT, Espersen F. The typing of Staphylococcus epidermidis by a lectin-binding assay. J Med Microbiol 1992, 37:195-200.

Hansen J-ES, Lihme A, Bøg-Hansen TC. The microheterogeneity components of orosomucoid and the dissociation constants and mobilities of Concanavalin A / orosomucoid complexes in crossed affinoimmunoelectrophoresis with free Concanavalin A. Electrophoresis 1984, 5:196-201.

Clinical medicine

Nielsen SD, Sørensen TU, Aladdin H, Ersbøll AK, Mathiesen L, Ullum H, Hansen J-ES, Pedersen BK. The effect of long-term treatment with granulocyte colony-stimulating factor (G-CSF) on hematopoiesis in HIV-infected individuals. Scand J Immunol 2000, 52:298-303.

Afzelius P, Nielsen SD, Nielsen JO, Hansen J-ES. Improvement of lymphocyte proliferation in human immunodeficiency virus infection after recombinant interleukin-2 treatment. Scand J Infect Dis 1999, 31:437-442.

Hansen J-ES. Virus, bakterier og toksiner som biologiske kampstoffer. Ugeskr Læger 1999, 161:772-775.

Skøt J, Kabrit P, Hansen J-ES, Nielsen JO, Nielsen L, Lundgren JD. Tumour necrosis factor and eicosanoid production from monocytes exposed to HIV in vitro. APMIS 1994, 102:603-611.

Nielsen TL, Schattenkerk JKME, Jensen BN, Lundgren JD, Gerstoft J, Van Steenwijk RP, Bentsen K, Frissen J, Gaub J, Orholm M, Hansen JE, Mathiesen L, Skinhøj P, Danner SA, Nielsen JO. Adjunctive corticosteroid therapy for Pneumocystis-carinii pneumonia in AIDS: A randomized european multicenter open label study. J Acquir Immune Defic Syndr Hum Retrovirol 1992, 5:726-731.

Hansen J-ES, Pedersen C. Microheterogeneity of orosomucoid and acute-phase reaction in AIDS patients. In: Breborowicz J, Mackiewicz A (eds.). Affinity electrophoresis: principles and application, CRC Press, New York, 1992, pp. 251-255.

Hansen J-ES, Bøg-Hansen TC, Pedersen B, Neland K. Microheterogeneity of orosomucoid in pathological conditions. Electrophoresis 1989, 10:574-578.

Hansen J-ES, Heegaard PMH, Jensen SP, Nørgaard-Pedersen B, Bøg-Hansen TC. Heterogeneity in copper and glycan content of ceruloplasmin in human serum differs in health and disease. Electrophoresis 1988, 9:273-278.

Hansen J-ES, Iversen J, Lihme A, Bøg-Hansen TC. Acute phase reaction, heterogeneity and microheterogeneity of serum proteins as non-specific tumor markers in lung cancer. Cancer 1987, 60:1630-1635.

Pedersen LE, Bonde J, Graudal NA, Backer NV, Hansen J-ES, Kampmann JP. Quantitative and qualitative binding characteristics of disopyramide in serum from patients with decreased renal and hepatic function. Br J Clin Pharm 1987, 23:41-46.

Damgaard AM, Heegaard P, Hansen J-ES, Bøg-Hansen TC. The microheterogeneity of the acute phase reactant alpha-1-antichymotrypsin in testicular and colorectal cancer. In: Peeters H (ed.). Protides of the Biological Fluids, Pergamon Press, Oxford 1986, vol. 34, pp. 449-452.

Hansen J-ES, Jensen SP, Nørgaard-Pedersen B, Bøg-Hansen TC. Electrophoretic analysis of the glycan microheterogeneity of orosomucoid in cancer and inflammation. Electrophoresis 1986, 7:180-183.

Hansen J-ES, Larsen VA, Bøg-Hansen TC. The microheterogeneity of alpha-1-acid glycoprotein in inflammatory lung disease, cancer of the lung and normal health. Clin Chim Acta 1984, 138:41-47.